Page last updated: 2024-08-21

allyl sulfide and Parkinsonian Disorders

allyl sulfide has been researched along with Parkinsonian Disorders in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bartoli, C; Corsini, GU; Dinucci, D; Pardini, C; Vaglini, F; Viaggi, C	1

Other Studies

1 other study(ies) available for allyl sulfide and Parkinsonian Disorders

Article	Year
Involvement of cytochrome P450 2E1 in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease. Journal of neurochemistry, 2004, Volume: 91, Issue:2 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Allyl Compounds; Animals; Blotting, Western; Cytochrome P-450 CYP2E1; Cytochrome P-450 CYP2E1 Inhibitors; Disease Models, Animal; Ditiocarb; Dopamine; Drug Synergism; Enzyme Inhibitors; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microdialysis; Neostriatum; Parkinsonian Disorders; Reverse Transcriptase Polymerase Chain Reaction; Substantia Nigra; Sulfides; Tyrosine 3-Monooxygenase	2004

Article

Year

Involvement of cytochrome P450 2E1 in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease.

Journal of neurochemistry, 2004, Volume: 91, Issue:2

Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Allyl Compounds; Animals; Blotting, Western; Cytochrome P-450 CYP2E1; Cytochrome P-450 CYP2E1 Inhibitors; Disease Models, Animal; Ditiocarb; Dopamine; Drug Synergism; Enzyme Inhibitors; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microdialysis; Neostriatum; Parkinsonian Disorders; Reverse Transcriptase Polymerase Chain Reaction; Substantia Nigra; Sulfides; Tyrosine 3-Monooxygenase

2004